367 related articles for article (PubMed ID: 18312579)
1. Intranasal immunization of mutant toxic shock syndrome toxin 1 elicits systemic and mucosal immune response against Staphylococcus aureus infection.
Narita K; Hu DL; Tsuji T; Nakane A
FEMS Immunol Med Microbiol; 2008 Apr; 52(3):389-96. PubMed ID: 18312579
[TBL] [Abstract][Full Text] [Related]
2. Immunization with glutathione S-transferase and mutant toxic shock syndrome toxin 1 fusion protein protects against Staphylococcus aureus infection.
Cui JC; Hu DL; Lin YC; Qian AD; Nakane A
FEMS Immunol Med Microbiol; 2005 Jul; 45(1):45-51. PubMed ID: 15985222
[TBL] [Abstract][Full Text] [Related]
3. Vaccination with nontoxic mutant toxic shock syndrome toxin 1 protects against Staphylococcus aureus infection.
Hu DL; Omoe K; Sasaki S; Sashinami H; Sakuraba H; Yokomizo Y; Shinagawa K; Nakane A
J Infect Dis; 2003 Sep; 188(5):743-52. PubMed ID: 12934191
[TBL] [Abstract][Full Text] [Related]
4. Vaccination with plasmid DNA encoding a mutant toxic shock syndrome toxin-1 ameliorates toxin-induced lethal shock in mice.
Feng MH; Cui JC; Nakane A; Hu DL
Tohoku J Exp Med; 2013 Sep; 231(1):1-8. PubMed ID: 23985881
[TBL] [Abstract][Full Text] [Related]
5. Cross-reactive antibodies prevent the lethal effects of Staphylococcus aureus superantigens.
Bavari S; Ulrich RG; LeClaire RD
J Infect Dis; 1999 Oct; 180(4):1365-9. PubMed ID: 10479174
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-10 (IL-10) Produced by Mutant Toxic Shock Syndrome Toxin 1 Vaccine-Induced Memory T Cells Downregulates IL-17 Production and Abrogates the Protective Effect against Staphylococcus aureus Infection.
Narita K; Hu DL; Asano K; Nakane A
Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31358568
[TBL] [Abstract][Full Text] [Related]
7. High Titer Persistent Neutralizing Antibodies Induced by TSST-1 Variant Vaccine Against Toxic Shock Cytokine Storm.
Roetzer A; Stich N; Model N; Schwameis M; Firbas C; Jilma B; Eibl MM
Toxins (Basel); 2020 Oct; 12(10):. PubMed ID: 33023185
[TBL] [Abstract][Full Text] [Related]
8. Detection of specific antibodies in cord blood, infant and maternal saliva and breast milk to staphylococcal toxins implicated in sudden infant death syndrome (SIDS).
Harrison LM; Morris JA; Bishop LA; Lauder RM; Taylor CA; Telford DR
FEMS Immunol Med Microbiol; 2004 Sep; 42(1):94-104. PubMed ID: 15325402
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of recombinant staphylococcal enterotoxin type C mutant vaccine against experimental bovine infection by a strain of Staphylococcus aureus isolated from subclinical mastitis in dairy cattle.
Chang BS; Moon JS; Kang HM; Kim YI; Lee HK; Kim JD; Lee BS; Koo HC; Park YH
Vaccine; 2008 Apr; 26(17):2081-91. PubMed ID: 18387721
[TBL] [Abstract][Full Text] [Related]
10. Vaccination with non-toxic mutant toxic shock syndrome toxin-1 induces IL-17-dependent protection against Staphylococcus aureus infection.
Narita K; Hu DL; Asano K; Nakane A
Pathog Dis; 2015 Jun; 73(4):. PubMed ID: 25857736
[TBL] [Abstract][Full Text] [Related]
11. Anti-staphylococcal humoral immune response in persistent nasal carriers and noncarriers of Staphylococcus aureus.
Verkaik NJ; de Vogel CP; Boelens HA; Grumann D; Hoogenboezem T; Vink C; Hooijkaas H; Foster TJ; Verbrugh HA; van Belkum A; van Wamel WJ
J Infect Dis; 2009 Mar; 199(5):625-32. PubMed ID: 19199541
[TBL] [Abstract][Full Text] [Related]
12. The effect of Staphylococcus aureus carriage in late pregnancy on antibody levels to staphylococcal toxins in cord blood and breast milk.
Harrison LM; Morris JA; Lauder RM; Telford DR
FEMS Immunol Med Microbiol; 2008 Oct; 54(1):137-43. PubMed ID: 18665847
[TBL] [Abstract][Full Text] [Related]
13. Toxic shock syndrome toxin-1 (TSST-1) antibody levels in Japanese children.
Quan L; Morita R; Kawakami S
Burns; 2010 Aug; 36(5):716-21. PubMed ID: 20036064
[TBL] [Abstract][Full Text] [Related]
14. Protection against Staphylococcus aureus sepsis by vaccination with recombinant staphylococcal enterotoxin A devoid of superantigenicity.
Nilsson IM; Verdrengh M; Ulrich RG; Bavari S; Tarkowski A
J Infect Dis; 1999 Oct; 180(4):1370-3. PubMed ID: 10479175
[TBL] [Abstract][Full Text] [Related]
15. Co-production of staphylococcal enterotoxin A with toxic shock syndrome toxin-1 (TSST-1) enhances TSST-1 mediated mortality in a D-galactosamine sensitized mouse model of lethal shock.
De Boer ML; Kum WW; Pang LT; Chow AW
Microb Pathog; 1999 Aug; 27(2):61-70. PubMed ID: 10458917
[TBL] [Abstract][Full Text] [Related]
16. Nonpurulent response to toxic shock syndrome toxin 1-producing Staphylococcus aureus. Relationship to toxin-stimulated production of tumor necrosis factor.
Fast DJ; Schlievert PM; Nelson RD
J Immunol; 1988 Feb; 140(3):949-53. PubMed ID: 3339245
[TBL] [Abstract][Full Text] [Related]
17. Immunity to Staphylococcus aureus secreted proteins protects rabbits from serious illnesses.
Spaulding AR; Lin YC; Merriman JA; Brosnahan AJ; Peterson ML; Schlievert PM
Vaccine; 2012 Jul; 30(34):5099-109. PubMed ID: 22691432
[TBL] [Abstract][Full Text] [Related]
18. Mucosal vaccination with recombinantly attenuated staphylococcal enterotoxin B and protection in a murine model.
Stiles BG; Garza AR; Ulrich RG; Boles JW
Infect Immun; 2001 Apr; 69(4):2031-6. PubMed ID: 11254555
[TBL] [Abstract][Full Text] [Related]
19. Intranasal vaccination with a double mutant of staphylococcal enterotoxin C provides protection against Staphylococcus aureus infection.
Hu DL; Omoe K; Narita K; Cui JC; Shinagawa K; Nakane A
Microbes Infect; 2006; 8(14-15):2841-8. PubMed ID: 17090392
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of staphylococcal enterotoxin A-induced superantigenic and lethal activities by a monoclonal antibody to toxic shock syndrome toxin-1.
Kum WW; Chow AW
J Infect Dis; 2001 Jun; 183(12):1739-48. PubMed ID: 11372026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
